Breast Cancer Screening, Mammography and "Alternative Facts"
“Some types of screening are a good idea — colorectal, for example,” said the lead author, Dr. Karsten Juhl Jorgensen, deputy director of the Nordic Cochrane Center. “But breast cancer has a biology that doesn’t lend itself to screening. Healthy women get a breast cancer diagnosis, and this has serious psychological consequences and well-known physical harms from unnecessary treatment. We’re really doing more harm than good.” The New York Times The Downside of Breast Cancer Screening
After reading the above NYT article, we wanted to explore both sides of the Breast Cancer Screening debate so we invited professionals and patients to weigh in with their opinions. We believe patients should be informed before making health care decisions and that includes reading evidence-based research reports as well as hearing personal narratives from patients who have gone through similar experiences.
Our intention with this series is to inform our readers about the facts surrounding breast cancer screening and the implications toward informed decision making.
Click here to read the series.
A Note from the CKN Team
CKN is recognized by the medical and patient communities as a reputable go-to resource, providing vetted and peer reviewed information as evidenced by the quality of our content and our writers. One of our top priorities is to provide our readers with current, evidence-based research about Complementary and Alternative Medicine (CAM), research that often doesn’t filter down to the patients.
Research has shown that the CAM decision-making process usually begins immediately following a cancer diagnosis; at the time of diagnosis, patients are particularly interested in CAM therapies that will enhance the effectiveness of their conventional treatment protocols and mediate potential side effects such as fatigue, nausea and vomiting, and anxiety; the information gathering and evaluation phase can be an anxiety-provoking experience for cancer patients.
As such, we’d like to extend a warm welcome to Dr. Hayley Erdman ND, who has joined our editorial team! Dr. Erdman will support our readers in these areas of CAM research by writing a bi-monthly blog series.
As always, we will balance this perspective by hearing from cancer patients and caregivers about their personal experiences around these issues.
Stay tuned and follow our content here.
Lorne Cooper - CEO, Multimed Inc.
Lorne’s ability to develop a conceptual model into practical programs and sustainable businesses is an expertise sought out by many corporations, non-profit organizations and small businesses. His ability to ascertain the marketplace and identify key opportunities for project development has been the cornerstone of his career.
Karen Irwin - CKN Project Co-ordinator
As Project Coordinator, Karen liaises with all CKN editors and writers and is responsible for managing the website and its editorial content. Karen brings her unique personal perspective to CKN, after losing her son to cancer at the age of 7. As a pediatric caregiver her experience and insight plays an important role.
Our content is authentic. Our connections are real. We've been
in the publishing industry for over 35 years.
Oncofertility Referral Network
Oncofertility has emerged as a new interdisciplinary approach to address the reproductive future of young men, women, and children facing a life-preserving but fertility threatening cancer diagnosis. The CKN Oncofertility Referral Network is a nationwide platform that links patients, physicians and fertility clinics to ensure time-sensitive needs are met in providing fertility options for young cancer patients as they embark on treatment.